These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 32378240)

  • 1. Efficacy and safety of adsorptive granulomonocytapheresis in Chinese patients with ulcerative colitis: A retrospective analysis of 50 cases with focus on factors impacting clinical efficacy.
    Li N; Mao J; Tang H; Zhu L; Tan X; Bi J; Wu H; Chen X; Wang Y
    J Clin Apher; 2020 Aug; 35(4):271-280. PubMed ID: 32378240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of children and adolescents with ulcerative colitis by adsorptive depletion of myeloid lineage leucocytes as monotherapy or in combination with low dose prednisolone after failure of first-line medications.
    Tanaka T; Sugiyama S; Goishi H; Kajihara T; Akagi M; Miura T
    BMC Gastroenterol; 2013 Aug; 13():130. PubMed ID: 23961883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adsorptive Granulocyte and Monocyte Apheresis in the Treatment of Ulcerative Colitis: The First Multicenter Study in China.
    Lai YM; Yao WY; He Y; Jiang X; Gu YB; Chen MH; Liu YL; Yuan YZ; Qian JM
    Gut Liver; 2017 Mar; 11(2):216-225. PubMed ID: 27843131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy, safety and cost analyses in ulcerative colitis patients undergoing granulocyte and monocyte adsorption or receiving prednisolone.
    Tominaga K; Nakano M; Hoshino M; Kanke K; Hiraishi H
    BMC Gastroenterol; 2013 Mar; 13():41. PubMed ID: 23452668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multicenter retrospective study aiming to identify patients who respond well to adsorptive granulomonocytapheresis in moderately to severely active ulcerative colitis.
    Yamamoto T; Iida T; Ikeya K; Kato M; Matsuura A; Tamura S; Takano R; Tani S; Osawa S; Sugimoto K; Shimoyama T; Hanai H
    Clin Transl Gastroenterol; 2018 Jul; 9(7):170. PubMed ID: 29977035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with treatment outcome, and long-term prognosis of patients with ulcerative colitis undergoing selective depletion of myeloid lineage leucocytes: a prospective multicenter study.
    Yokoyama Y; Watanabe K; Ito H; Nishishita M; Sawada K; Okuyama Y; Okazaki K; Fujii H; Nakase H; Masuda T; Fukunaga K; Andoh A; Nakamura S
    Cytotherapy; 2015 May; 17(5):680-8. PubMed ID: 25804800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Safety of Adsorptive Granulocyte and Monocyte Apheresis in Elderly and Pregnant Patients With Ulcerative Colitis.
    Yanagisawa K; Murakami M; Kondo Y; Oguma S; Kobayashi S; Miyasaka H; Shinohara T; Tomori A; Nakano Y; Furuhata S; Ikezoe M
    Ther Apher Dial; 2019 Jun; 23(3):217-223. PubMed ID: 31025815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Faecal calprotectin level for assessing endoscopic activity and predicting future clinical course in patients with moderately active ulcerative colitis undergoing granulomonocytapheresis: a prospective cohort study.
    Shimoyama T; Yamamoto T; Umegae S; Matsumoto K
    BMC Gastroenterol; 2018 Aug; 18(1):120. PubMed ID: 30068300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adsorptive granulomonocytapheresis alters the gut bacterial microbiota in patients with active ulcerative colitis.
    Chen X; Lou L; Tang H; Tan X; Bi J; Wu H; Li N; Wang Y; Mao J
    J Clin Apher; 2021 Jun; 36(3):454-464. PubMed ID: 33598970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Processed blood volume impacts clinical efficacy in patients with ulcerative colitis undergoing adsorptive depletion of myeloid lineage leucocytes.
    Yoshimura N; Tadami T; Kawaguchi T; Sako M; Yoshimoto H; Yamaka T; Takazoe M
    J Gastroenterol; 2012 Jan; 47(1):49-55. PubMed ID: 21915624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Granulomonocytapheresis as a cell-dependent treatment option for patients with inflammatory bowel disease: Concepts and clinical features for better therapeutic outcomes.
    Saniabadi AR; Tanaka T; Yamamoto T; Kruis W; Sacco R
    J Clin Apher; 2019 Feb; 34(1):51-60. PubMed ID: 30407662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adsorptive Depletion of Myeloid Lineage Leucocytes as Remission Induction Therapy in Patients with Ulcerative Colitis after Failure of First-Line Medications: Results from a Three-Year Real World, Clinical Practice.
    Iida T; Ikeya K; Kato M; Abe J; Yamamoto M; Watanabe F; Sugimoto K; Hanai H
    Digestion; 2017; 96(2):119-126. PubMed ID: 28796990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In patients with ulcerative colitis, adsorptive depletion of granulocytes and monocytes impacts mucosal level of neutrophils and clinically is most effective in steroid naïve patients.
    Tanaka T; Okanobu H; Yoshimi S; Murakami E; Kogame A; Imagawa H; Numata Y; Kuga Y; Moriya T; Ohya T; Kajiyama G
    Dig Liver Dis; 2008 Sep; 40(9):731-6. PubMed ID: 18387860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adsorptive depletion of alpha4 integrin(hi)- and CX3CR1hi-expressing proinflammatory monocytes in patients with ulcerative colitis.
    Takeda S; Sato T; Katsuno T; Nakagawa T; Noguchi Y; Yokosuka O; Saito Y
    Dig Dis Sci; 2010 Jul; 55(7):1886-95. PubMed ID: 19908144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Daily granulocyte and monocyte adsorptive apheresis in patients with active ulcerative colitis: a prospective safety and feasibility study.
    Yamamoto T; Umegae S; Matsumoto K
    J Gastroenterol; 2011 Aug; 46(8):1003-9. PubMed ID: 21681409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with the outcomes in ulcerative colitis patients undergoing granulocyte and monocyte adsorptive apheresis as remission induction therapy: A multicenter cohort study.
    Ishiguro Y; Ohmori T; Umemura K; Iizuka M
    Ther Apher Dial; 2021 Aug; 25(4):502-512. PubMed ID: 33029920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Looking for predictive factors of clinical response to adsorptive granulocyte and monocyte apheresis in patients with ulcerative colitis: markers of response to GMA.
    Yokoyama Y; Kawai M; Fukunaga K; Kamikozuru K; Nagase K; Nogami K; Kono T; Ohda Y; Iimuro M; Hida N; Nakamura S; Miwa H; Matsumoto T
    BMC Gastroenterol; 2013 Feb; 13():27. PubMed ID: 23399416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treating inflammatory bowel disease by adsorptive leucocytapheresis: a desire to treat without drugs.
    Saniabadi AR; Tanaka T; Ohmori T; Sawada K; Yamamoto T; Hanai H
    World J Gastroenterol; 2014 Aug; 20(29):9699-715. PubMed ID: 25110409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adacolumn leucocytapheresis for ulcerative colitis: clinical and endoscopic features of responders and unresponders.
    Sacco R; Tanaka T; Yamamoto T; Bresci G; Saniabadi AR
    Expert Rev Gastroenterol Hepatol; 2015 Mar; 9(3):327-33. PubMed ID: 25160857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of granulocyte and monocyte adsorption apheresis in paediatric inflammatory bowel disease: a prospective pilot study.
    Martín de Carpi J; Vilar P; Prieto G; García Novo MD; Ribes C; Varea V
    J Pediatr Gastroenterol Nutr; 2008 Apr; 46(4):386-91. PubMed ID: 18367949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.